{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:58:10Z","timestamp":1784260690610,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017035","name":"Center for AIDS Research, Johns Hopkins University","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100017035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA045556"],"award-info":[{"award-number":["R01DA045556"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA035684"],"award-info":[{"award-number":["K24DA035684"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dadr.2024.100288","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:12:55Z","timestamp":1728407575000},"page":"100288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD"],"prefix":"10.1016","volume":"13","author":[{"given":"Tarfa","family":"Verinumbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Zook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Falade-Nwulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.dadr.2024.100288_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.15585\/mmwr.mm6916a2","article-title":"Notes from the field: outbreak of human immunodeficiency virus infection among persons who inject drugs - cabell county, West Virginia, 2018-2019","volume":"69","author":"Atkins","year":"2020","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"issue":"12","key":"10.1016\/j.dadr.2024.100288_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/apc.2018.0126","article-title":"Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs","volume":"32","author":"Bazzi","year":"2018","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"10.1016\/j.dadr.2024.100288_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","article-title":"Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs","volume":"15","author":"Biello","year":"2018","journal-title":"Harm. Reduct. J."},{"issue":"6","key":"10.1016\/j.dadr.2024.100288_bib4","first-page":"1","article-title":"HIV infection and risk, prevention, and testing behaviors among injecting drug users - National HIV Behavioral Surveillance System, 20 U.S. cities, 2009","volume":"63","author":"Broz","year":"2014","journal-title":"MMWR Surveill Summ."},{"issue":"16","key":"10.1016\/j.dadr.2024.100288_bib5","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.dadr.2024.100288_bib6","series-title":"HIV Surveillance Report 2021","author":"CDC","year":"2021"},{"issue":"2","key":"10.1016\/j.dadr.2024.100288_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/JAN.0000000000000522","article-title":"An assessment of HIV Risk, perceptions of risk, and potential adherence to preexposure prophylaxis among HIV-negative people with injection drug use who access mobile outreach services","volume":"34","author":"Champion","year":"2023","journal-title":"J. Addict. Nurs."},{"issue":"9883","key":"10.1016\/j.dadr.2024.100288_bib8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.dadr.2024.100288_bib9","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone-Indiana, 2015","volume":"64","author":"Conrad","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"3","key":"10.1016\/j.dadr.2024.100288_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10826084.2021.2012688","article-title":"Awareness and correlates of HIV pre-exposure prophylaxis (PrEP) among HIV-negative people who access syringe services in seattle, Washington","volume":"57","author":"Corcorran","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"7","key":"10.1016\/j.dadr.2024.100288_bib11","first-page":"1771","article-title":"Perceived Candidacy for Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men in Paris, France","volume":"23","author":"Dubin","year":"2019","journal-title":"AIDS\u00a0Behav."},{"issue":"13","key":"10.1016\/j.dadr.2024.100288_bib12","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1007\/s11606-023-08040-7","article-title":"Provider implicit bias in prescribing HIV pre-exposure prophylaxis (PrEP) to people who inject drugs","volume":"38","author":"Dubov","year":"2023","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.dadr.2024.100288_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.dadr.2024.100288_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.copsyc.2015.03.012","article-title":"Risk perceptions and health behavior","volume":"5","author":"Ferrer","year":"2015","journal-title":"Curr. Opin. Psychol."},{"issue":"1","key":"10.1016\/j.dadr.2024.100288_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0033354921994202","article-title":"Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019","volume":"137","author":"Furukawa","year":"2022","journal-title":"Public Health Rep."},{"issue":"4","key":"10.1016\/j.dadr.2024.100288_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae107","article-title":"An analysis of social determinants of health and their implications for Hepatitis C virus treatment in people who inject drugs: the case of Baltimore","volume":"11","author":"Gonzalez Corro","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.dadr.2024.100288_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231424","article-title":"Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida","volume":"15","author":"Jo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.dadr.2024.100288_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10461-019-02637-y","article-title":"The Effect of Social Networks and Social Constructions on HIV Risk Perceptions","volume":"24","author":"Koku","year":"2020","journal-title":"AIDS and Behavior"},{"issue":"5","key":"10.1016\/j.dadr.2024.100288_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the united states: a narrative review","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"issue":"10013","key":"10.1016\/j.dadr.2024.100288_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.dadr.2024.100288_bib21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s10461-019-02682-7","article-title":"Low PrEP awareness and use among people who inject drugs, San Francisco, 2018","volume":"24","author":"McFarland","year":"2020","journal-title":"AIDS Behav."},{"issue":"5","key":"10.1016\/j.dadr.2024.100288_bib22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","article-title":"The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review","volume":"25","author":"Mistler","year":"2021","journal-title":"AIDS Behav"},{"issue":"23","key":"10.1016\/j.dadr.2024.100288_bib23","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2024.100288_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108477","article-title":"Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment","volume":"219","author":"Ni","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.dadr.2024.100288_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","article-title":"Defining the HIV pre-exposure prophylaxis care continuum","volume":"31","author":"Nunn","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.dadr.2024.100288_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/add.16486","article-title":"Integrated care van delivery of evidence-based services for people who inject drugs: a cluster-randomized trial","author":"Page","year":"2024","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.dadr.2024.100288_bib27","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dadr.2024.100288_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/21501319211063999","article-title":"Evidence of potential discriminatory HIV pre-exposure prophylaxis (PrEP) prescribing practices for people who inject drugs among a small percentage of providers in the U.S","volume":"13","author":"Pleuhs","year":"2022","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.dadr.2024.100288_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.socscimed.2016.10.030","article-title":"Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): findings from a large cohort of gay and bisexual men in the U.S","volume":"172","author":"Rendina","year":"2017","journal-title":"Social Sci.\u00a0Med."},{"issue":"4","key":"10.1016\/j.dadr.2024.100288_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/OLQ.0000000000000728","article-title":"An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users","volume":"45","author":"Roth","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"10","key":"10.1016\/j.dadr.2024.100288_bib31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/09540121.2018.1447079","article-title":"HIV risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system","volume":"30","author":"Rutledge","year":"2018","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.dadr.2024.100288_bib32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/09540121.2020.1822506","article-title":"Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia","volume":"33","author":"Schneider","year":"2021","journal-title":"AIDS Care"},{"key":"10.1016\/j.dadr.2024.100288_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2018.08.014","article-title":"PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland","volume":"195","author":"Sherman","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.dadr.2024.100288_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.12.023","article-title":"Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment","volume":"173","author":"Shrestha","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.dadr.2024.100288_bib35","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","article-title":"Willingness to use HIV pre-exposure prophylaxis among opiate users","volume":"18","author":"Stein","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.dadr.2024.100288_bib36","series-title":"World Drug Report 2023","author":"UNODC","year":"2023"},{"key":"10.1016\/j.dadr.2024.100288_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103873","article-title":"Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs","volume":"110","author":"Vincent","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1016\/j.dadr.2024.100288_bib38","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s10461-021-03488-2","article-title":"PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure","volume":"26","author":"Walters","year":"2022","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.dadr.2024.100288_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11524-018-0238-6","article-title":"Correlates of sexual coercion among people who inject drugs (PWID) in Los Angeles and San Francisco, CA","volume":"96","author":"Williams","year":"2019","journal-title":"J. Urban Health"},{"issue":"3","key":"10.1016\/j.dadr.2024.100288_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000002354","article-title":"Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: the TAF-DBS Study","volume":"84","author":"Yager","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.dadr.2024.100288_bib41","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s10461-023-04008-0","article-title":"HIV risk perception, willingness to use PrEP, and PrEP uptake among young men who have sex with men in Washington, DC","volume":"27","author":"Yellin","year":"2023","journal-title":"AIDS Behav."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T08:29:40Z","timestamp":1736670580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S2772724624000726"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100288","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100288"}}